- Fund Type: Closed-End Fund
- Objective: Sector Fund-Health & Biotech
- Asset Class: Equity
- Geographic Focus: U.S.
H&Q Healthcare Investors
+ Add to WatchlistHQH:US
21.9441 USD 0.2959 1.33%As of 11:51:28 ET on 06/19/2013.
Snapshot for H&Q Healthcare Investors (HQH)
| Open: | 22.1000 | High - Low: | 22.2300 - 21.9100 | Primary Exchange: | New York |
|---|---|---|---|---|---|
| Volume: | 43,631 | 52-Week Range: | 15.6500 - 24.2190 | Beta vs BTK: | 0.6508 |
Fund Profile & Information for HQH
H&Q Healthcare Investors is a diversified, closed-end management investment company incorporated in the USA. The Trust's objective seeks long-term capital appreciation. The Trust will invest 80% of its assets in health services and medical technology companies, that have significant potential for above-average growth.
| Inception Date: | 1987-04-22 | Telephone: | 1-617-772-8500 |
|---|---|---|---|
| Managers: | DANIEL R OMSTEAD | ||
| Web Site: | www.teklacap.com | ||
Fundamentals for HQH
| NAV | (on 2013-06-18) 22.2600 |
|---|---|
| Assets (M) | (on 2013-06-18) 604.8070 |
| Shares out (M) | 27.17 |
| Market Cap (M) | 596.12 |
| % Premium | -0.09 |
| Average 52-Week % Premium | -4.2232 |
| Fund Leveraged | N |
Dividends for HQH
| Dividend Type | Income |
|---|---|
| Dividend Frequency | Quarter |
| Last Dividend Net | (on 2013-05-23) 0.4200 |
| Dividend Yield (ttm) | 6.97% |
Performance for HQH
| 1-Month | -0.34% | 1-Year | +47.01% |
|---|---|---|---|
| 3-Month | +17.68% | 3-Year | +33.90% |
| Year To Date | +33.36% | 5-Year | +16.13% |
| Expense Ratio | 1.42 |
Top Fund Holdings for HQH
Filing Date: 12/31/2012| Name | Position | Value | % of Total |
|---|---|---|---|
| Gilead Sciences Inc | 1,039,942 | 38,191,870 | 7.703% |
| Regeneron Pharmaceuticals Inc | 210,044 | 35,932,227 | 7.248% |
| Celgene Corp | 403,533 | 31,766,118 | 6.407% |
| Biogen Idec Inc | 151,080 | 22,158,904 | 4.470% |
| Alexion Pharmaceuticals Inc | 231,115 | 21,680,897 | 4.373% |
| Puma Biotechnology Inc | 762,910 | 14,304,562 | 2.885% |
| Perrigo Co | 136,379 | 14,187,507 | 2.862% |
| Mylan Inc/PA | 501,580 | 13,783,418 | 2.780% |
| Merck & Co Inc | 296,620 | 12,143,623 | 2.449% |
| Hologic Inc | 561,739 | 11,251,632 | 2.269% |
Quotes delayed, except where indicated otherwise. Mutual fund NAVs include dividends. All prices in local currency. Time is ET.
Sponsored Financial Commentaries
Advertisement
Top Forex Trading Resources
- 1
- 2
- 3
- 4
- 5
Advertisement
Advertisement
Sponsored Links
Advertisements
Rate this Page